Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Cancer

Explore clinical trials studying Triple Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

298 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Cancer trial results

Completed

Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies

NCT02807844

Conditions
Breast Diseases, Breast Neoplasms, Digestive System Diseases, +31 more
Locations
  • Dana Farber Cancer Center Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • The West Clinic Germantown, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View all 20 locations
View Trial Details
Completed

A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer

NCT02032277

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Scottsdale Healthcare /ID# 120473 Scottsdale, Arizona, United States
  • Mayo Clinic - Scottsdale /ID# 139932 Scottsdale, Arizona, United States
  • Arizona Oncology Associates, PC-HOPE /ID# 126137 Tucson, Arizona, United States
  • Usc /Id# 123310 Los Angeles, California, United States
View all 158 locations
View Trial Details
Completed

PCA062 in pCAD-positive Tumors.

NCT02375958

Conditions
Breast Diseases, Breast Neoplasms, Digestive System Diseases, +14 more
Locations
  • Novartis Investigative Site Houston, Texas, United States
  • Novartis Investigative Site San Antonio, Texas, United States
  • Novartis Investigative Site Villejuif, France
  • Novartis Investigative Site Milan, MI, Italy
View Trial Details

Related conditions